Browsing Over 154 Presentations
Sort By
Welcome from the Congress Chairs / Treatment of ovarian cancer in 2023
Educational session
How to select the best first line maintenance treatment? Is molecular profiling the only criteria to choose?
Lecture Time
08:50 - 09:05
Speakers
- Isabelle L. Ray-Coquard (Lyon, France)
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
08:25 - 09:50
Welcome from the Congress Chairs / Treatment of ovarian cancer in 2023
Educational session
Welcome to the ESMO Gynaecological Cancers Congress 2023
Lecture Time
08:25 - 08:30
Speakers
- The Chairs (Barcelona, Spain)
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
08:25 - 09:50
Welcome from the Congress Chairs / Treatment of ovarian cancer in 2023
Educational session
New treatment in the current ovarian cancer beyond ADCs
Lecture Time
09:05 - 09:20
Speakers
- Nicoletta Colombo (Milan, Italy)
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
08:25 - 09:50
Welcome from the Congress Chairs / Treatment of ovarian cancer in 2023
Educational session
PARP inhibitors: Mechanism of resistance and how to overcome
Lecture Time
09:20 - 09:35
Speakers
- Iain McNeish (London, United Kingdom)
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
08:25 - 09:50
Welcome from the Congress Chairs / Treatment of ovarian cancer in 2023
Educational session
Q&A
Lecture Time
09:35 - 09:50
Speakers
- All Speakers (Barcelona, Spain)
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
08:25 - 09:50
Welcome from the Congress Chairs / Treatment of ovarian cancer in 2023
Educational session
Introduction
Lecture Time
08:30 - 08:35
Speakers
- Susana Banerjee (London, United Kingdom)
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
08:25 - 09:50
Welcome from the Congress Chairs / Treatment of ovarian cancer in 2023
Educational session
Do we still need radical surgery in the PARP inhibitor era?
Lecture Time
08:35 - 08:50
Speakers
- GIOVANNI Scambia (Rome, Italy)
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
08:25 - 09:50
How to interpret overall survival data with PARP inhibitors
Special Symposium
Why are we having this Symposium? Recent regulatory actions by FDA/EMEA regarding late-stage approval for PARPi in recurrent ovarian cancer
Lecture Time
10:15 - 10:30
Speakers
- Robert L. Coleman (The Woodlands, TX, United States of America)
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
10:15 - 11:35
How to interpret overall survival data with PARP inhibitors
Special Symposium
Is there clinical evidence to support the link between PARPi use and a negative impact on OS?
Lecture Time
10:30 - 10:45
Speakers
- Jonathan A. Ledermann (London, United Kingdom)
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
10:15 - 11:35
How to interpret overall survival data with PARP inhibitors
Special Symposium
Is there a biological rationale to support decremental impact on overall survival?
Lecture Time
10:45 - 11:00
Speakers
- Antonio Jose Gonzalez Martin (Madrid, Spain)
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
10:15 - 11:35
How to interpret overall survival data with PARP inhibitors
Special Symposium
Q&A
Lecture Time
11:15 - 11:50
Speakers
- All Speakers (Barcelona, Spain)
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
10:15 - 11:35
Proffered Paper session
Proffered Paper session
Invited Discussant of abstract 35O
Lecture Time
12:32 - 12:37
Speakers
- Jonathan A. Ledermann (London, United Kingdom)
Session Name
Room
Auditorium 113
Date
Thu, 23.02.2023
Time
11:45 - 12:45